These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 35530147)

  • 61. Xenobiotic receptors in mediating the effect of sepsis on drug metabolism.
    Lv C; Huang L
    Acta Pharm Sin B; 2020 Jan; 10(1):33-41. PubMed ID: 31993305
    [TBL] [Abstract][Full Text] [Related]  

  • 62. WDR23 regulates the expression of Nrf2-driven drug-metabolizing enzymes.
    Siswanto FM; Oguro A; Arase S; Imaoka S
    Drug Metab Pharmacokinet; 2020 Oct; 35(5):441-455. PubMed ID: 32839090
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changes and sex- and age-related differences in the expression of drug metabolizing enzymes in a KRAS-mutant mouse model of lung cancer.
    Li X; Lu Y; Ou X; Zeng S; Wang Y; Qi X; Zhu L; Liu Z
    PeerJ; 2020; 8():e10182. PubMed ID: 33240601
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes.
    Achour B; Al Feteisi H; Lanucara F; Rostami-Hodjegan A; Barber J
    Drug Metab Dispos; 2017 Jun; 45(6):666-675. PubMed ID: 28373266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Xenobiotic Metabolism and Gut Microbiomes.
    Das A; Srinivasan M; Ghosh TS; Mande SS
    PLoS One; 2016; 11(10):e0163099. PubMed ID: 27695034
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction by Phenobarbital of Phase I and II Xenobiotic-Metabolizing Enzymes in Bovine Liver: An Overall Catalytic and Immunochemical Characterization.
    Cantiello M; Carletti M; Giantin M; Gardini G; Capolongo F; Cascio P; Pauletto M; Girolami F; Dacasto M; Nebbia C
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408925
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Developmental regulation of kidney and liver solute carrier and ATP-binding cassette drug transporters and drug metabolizing enzymes: the role of remote organ communication.
    Momper JD; Nigam SK
    Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):561-570. PubMed ID: 29746174
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High-throughput and combinatorial gene expression on a chip for metabolism-induced toxicology screening.
    Kwon SJ; Lee DW; Shah DA; Ku B; Jeon SY; Solanki K; Ryan JD; Clark DS; Dordick JS; Lee MY
    Nat Commun; 2014 May; 5():3739. PubMed ID: 24799042
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative protein profiling of phenobarbital-induced drug metabolizing enzymes in rat liver by liquid chromatography mass spectrometry using formalin-fixed paraffin-embedded samples.
    Yamauchi H; Andou T; Watanabe T; Gotou M; Anayama H
    J Pharmacol Toxicol Methods; 2021; 112():107107. PubMed ID: 34363961
    [TBL] [Abstract][Full Text] [Related]  

  • 71. INTEDE 2.0: the metabolic roadmap of drugs.
    Zhang Y; Liu X; Li F; Yin J; Yang H; Li X; Liu X; Chai X; Niu T; Zeng S; Jia Q; Zhu F
    Nucleic Acids Res; 2024 Jan; 52(D1):D1355-D1364. PubMed ID: 37930837
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A Molecular Aspect in the Regulation of Drug Metabolism: Does PXR-Induced Enzyme Expression Always Lead to Functional Changes in Drug Metabolism?
    Wei Y; Tang C; Sant V; Li S; Poloyac SM; Xie W
    Curr Pharmacol Rep; 2016 Aug; 2(4):187-192. PubMed ID: 27795941
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The evolving role of drug metabolism in drug discovery and development.
    Yengi LG; Leung L; Kao J
    Pharm Res; 2007 May; 24(5):842-58. PubMed ID: 17333392
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug metabolism by tumours: its nature, relevance and therapeutic implications.
    Michael M; Doherty MM
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):783-803. PubMed ID: 18028025
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine.
    Shah RR; Smith RL
    Drug Metab Dispos; 2015 Mar; 43(3):400-10. PubMed ID: 25519488
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
    Sim SC; Kacevska M; Ingelman-Sundberg M
    Pharmacogenomics J; 2013 Feb; 13(1):1-11. PubMed ID: 23089672
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enzyme- and transporter-mediated drug interactions with small molecule tyrosine kinase inhibitors.
    Shao J; Markowitz JS; Bei D; An G
    J Pharm Sci; 2014 Dec; 103(12):3810-3833. PubMed ID: 25308414
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes.
    Okey AB; Boutros PC; Harper PA
    Pharmacogenet Genomics; 2005 Jun; 15(6):371-9. PubMed ID: 15900209
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes.
    Ung YT; Ong CE; Pan Y
    High Throughput; 2018 Sep; 7(4):. PubMed ID: 30274310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.